TEMSAMANI; JAMAL

Patent Applications and Registrations

Patent applications and USPTO patent grants for TEMSAMANI; JAMAL.The latest application filed is for "compositions and methods for cancer imaging and radiotherapy".

Company Profile

1.9.12

TEMSAMANI; JAMAL - NIMES FR
Temsamani; Jamal - Nimes Cedex FR
Temsamani; Jamal - N mes FR
Temsamani; Jamal - Worcester MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions And Methods For Cancer Imaging And Radiotherapy App 20190351079 - MALICET; CEDRIC ; et al.	2019-11-21
Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases Grant 9,468,662 - Laruelle , et al. October 18, 2	2016-10-18
Use Of The Pat Nonapeptide In The Treatment And Prevention Of Neurodegenerative Diseases App 20160074463 - LARUELLE; Claude ; et al.	2016-03-17
Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases Grant 9,192,654 - Temsamani , et al. November 24, 2	2015-11-24
Use Of The Pat Nonapeptide In Treating And Preventing Neurodegenerative Diseases App 20130116193 - Temsamani; Jamal ; et al.	2013-05-09
Use Of The Pat Nanopeptide In The Treatment Of Autoimmune Diseases App 20110098223 - Temsamani; Jamal ; et al.	2011-04-28
Pharmaceutical composition comprising an anti-cancer and at least a peptide Grant 7,527,792 - Temsamani , et al. May 5, 2	2009-05-05
Peptides carrying substances across the blood brain barrier Grant 7,399,747 - Clair , et al. July 15, 2	2008-07-15
Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses Grant 7,365,055 - Temsamani , et al. April 29, 2	2008-04-29
Use of peptide vectors to improve the immune response to antigens Grant 7,314,626 - Johnson , et al. January 1, 2	2008-01-01
Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation App 20070161553 - Mathieu; Daniele ; et al.	2007-07-12
Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses App 20070116665 - Temsamani; Jamal ; et al.	2007-05-24
Transporting of taxoid derivatives through the blood brain barrier App 20060293242 - Temsamani; Jamal ; et al.	2006-12-28
Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases App 20050159360 - Temsamani, Jamal ; et al.	2005-07-21
Use of peptide vectors to improve the immune response to antigens App 20040072340 - Johnson, Mark Elliott ; et al.	2004-04-15
Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response Grant 6,667,293 - Zhao , et al. December 23, 2	2003-12-23
Amphipathic linear peptides and formulations containing said peptides App 20030186890 - Drin, Guillaume ; et al.	2003-10-02
Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response App 20030148981 - Zhao, Qiuyan ; et al.	2003-08-07
Method of modulating gene expression with reduced immunostimulatory response Grant 5,968,909 - Agrawal , et al. October 19, 1	1999-10-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.